文献

J-GLOBAL ID：201202209311944570   整理番号：12A1670586

抗不整脈デバイス治療は心アミロイドーシス患者の予後改善に限界がある

Anti-arrhythmic device therapy has limits in improving the prognosis of patients with cardiac amyloidosis

著者 (14件)： KOJIMA Toshiya (Dep. of Cardiovascular Medicine, The Univ. of Tokyo Graduate School of Medicine) ,  IMAI Yasushi (Dep. of Cardiovascular Medicine, The Univ. of Tokyo Graduate School of Medicine) ,  FUJIU Katsuhito (Dep. of Cardiovascular Medicine, The Univ. of Tokyo Graduate School of Medicine) ,  FUJIU Katsuhito (Translational Systems Biology and Medicine Initiative, The Univ. of Tokyo Graduate School of Medicine) ,  SUZUKI Takeki (Dep. of Cardiovascular Medicine, The Univ. of Tokyo Graduate School of Medicine) ,  SUGIYAMA Hiroaki (Dep. of Cardiovascular Medicine, The Univ. of Tokyo Graduate School of Medicine) ,  ASADA Kazuo (Dep. of Cardiovascular Medicine, The Univ. of Tokyo Graduate School of Medicine) ,  AJIKI Kohsuke (Cardiovascular Center, JR Tokyo General Hospital) ,  HAYAMI Noriyuki (Fourth Dep. of Internal Medicine, Teikyo Univ. School of Medicine) ,  MURAKAWA Yuji (Fourth Dep. of Internal Medicine, Teikyo Univ. School of Medicine) ,  NAGAI Ryozo (Dep. of Cardiovascular Medicine, The Univ. of Tokyo Graduate School of Medicine) ,  NAGAI Ryozo (Translational Systems Biology and Medicine Initiative, The Univ. of Tokyo Graduate School of Medicine) ,  NAGAI Ryozo (Global COE, The Univ. of Tokyo Graduate School of Medicine) ,  NAGAI Ryozo (Translational Res. Center, The Univ. of Tokyo Graduate School of Medicine)
資料名： Journal of Arrhythmia  (Journal of Arrhythmia)
巻： 28  号： 4  ページ： 242-246 (J-STAGE)  発行年： 2012年 
JST資料番号： Y0127A  ISSN： 1880-4276  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 免疫グロブリン軽鎖(AL)アミロイドーシスは長期予後が不良で...

シソーラス用語： *アミロイドーシス ,...
準シソーラス用語： ALアミロイドーシス ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=12A1670586&from=J-GLOBAL&jstjournalNo=Y0127A") }}

分類 (2件)： 医療用機器装置  (GA05020L) ,  循環系疾患の治療一般  (GJ05010B)

引用文献 (18件)：

• [1] Dubrey SW, Cha K, Anderson J, et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. Q J Math 1998;91:141-157.
• [2] Falk RH, Skinner M. The systemic amyloidoses: an overview. Adv Intern Med 2000;45:107-137.
• [3] Kyle RA, Greipp PR. Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc 1983;58:665-683.
• [4] Cohen AS, Rubinow A, Anderson JJ, et al. Survival of patients with primary (AL) amyloidosis. colchicine-treated cases from 1976 to 1983 compared with cases seen in previous years (1961 to 1973). Am J Med 1987;82:1182-1190.
• [5] Kyle RA, Gertz MA, Greipp PR, et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 1997;336:1202-1207.

タイトルに関連する用語 (5件)： 不整脈 ,  治療 ,  心アミロイドーシス ,  患者の予後 ,  限界